» Articles » PMID: 2880319

The Effects of Buspirone on Sleep in the Rat

Overview
Journal Neurosci Lett
Specialty Neurology
Date 1986 Dec 3
PMID 2880319
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Buspirone is a novel anxiolytic compound that does not produce the sedation often associated with the use of benzodiazepines. The present study evaluated the effects of this anxiolytic on sleep in rats surgically prepared for long-term recordings. Buspirone, at a dose of 3 mg/kg i.p., produced a significant increase in total wake time (P less than 0.05) compared with drug-free controls. At a dose of 10 mg/kg i.p., rats displayed altered sleep patterns with the most significant effects observed in the first third of recording period. These animals displayed increased wakefulness (P less than 0.001), decreased non-REM sleep (P less than 0.001), and an obliteration of REM sleep (P less than 0.02). These data support the suggestion that the clinically useful anxiolytic buspirone, unlike the benzodiazepines, does not induce sleep.

Citing Articles

Sleep disturbances in autism spectrum disorder: Animal models, neural mechanisms, and therapeutics.

Maurer J, Choi A, An I, Sathi N, Chung S Neurobiol Sleep Circadian Rhythms. 2023; 14:100095.

PMID: 37188242 PMC: 10176270. DOI: 10.1016/j.nbscr.2023.100095.


Behavioral Effects of Buspirone in Juvenile Zebrafish of Two Different Genetic Backgrounds.

Abozaid A, Gerlai R Toxics. 2022; 10(1).

PMID: 35051064 PMC: 8777658. DOI: 10.3390/toxics10010022.


8-OH-DPAT regulates the amplitude and the phase of LH surge in ovariectomized steroid-primed rats.

Hery M, Francois-Bellan A, Hery F Endocrine. 2010; 3(10):751-4.

PMID: 21153165 DOI: 10.1007/BF03000208.


The serotonergic system may be involved in the sleep-inducing action of oleamide in rats.

Yang J, Wu C, Wang F, Song H, Pan W, Wang Y Naunyn Schmiedebergs Arch Pharmacol. 2003; 368(6):457-62.

PMID: 14615880 DOI: 10.1007/s00210-003-0843-z.


Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers.

Gillin J, Jernajczyk W, Golshan S, Lardon M, Stahl S Psychopharmacology (Berl). 1994; 116(4):433-6.

PMID: 7701045 DOI: 10.1007/BF02247474.